---
title: 'Venlafaxine''s therapeutic reference range in the treatment of depression
  revised: a systematic review and meta-analysis'
date: '2023-10-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37857898/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231020180831&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: VEN TDM within a range of 140 to 600 ng/ml (AM) will increase
  the probability of response in nonresponders. A titration within the proposed reference
  range is recommended in case of non-response at lower drug concentrations as a consequence
  of VEN''s dual mechanism of action via combined serotonin and norepinephrine reuptake
  inhibition. Drug titration towards higher concentrations will, however, increase
  the risk for ADRs, in particular with supratherapeutic drug ...'
disable_comments: true
---
CONCLUSION: VEN TDM within a range of 140 to 600 ng/ml (AM) will increase the probability of response in nonresponders. A titration within the proposed reference range is recommended in case of non-response at lower drug concentrations as a consequence of VEN's dual mechanism of action via combined serotonin and norepinephrine reuptake inhibition. Drug titration towards higher concentrations will, however, increase the risk for ADRs, in particular with supratherapeutic drug ...